Altimmune, Inc. (ALT)
3.61
-0.07
(-1.90%)
USD |
NASDAQ |
Dec 30, 16:00
3.61
0.00 (0.00%)
After-Hours: 05:12
Altimmune EPS Diluted (Quarterly): -0.2126 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -0.8083 |
| Amgen, Inc. | 5.934 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
| Terns Pharmaceuticals, Inc. | -0.2686 |
| X4 Pharmaceuticals, Inc. | -0.689 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.01M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 19.02M |
| Enterprise Value | 181.76M |
| Gross Profit Margin (Quarterly) | -440.0% |
| Profit Margin (Quarterly) | -380.3K% |
| Earnings Yield | -29.61% |
| Normalized Earnings Yield | -29.61 |